Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saw palmetto + sanmiaoshan is a combination dietary supplement containing saw palmetto (Serenoa repens) and an ingredient referred to as "sanmiaoshan." Saw palmetto is a well-known herbal extract commonly used for symptoms associated with benign prostatic hyperplasia (BPH), such as urinary frequency and decreased urine flow. Its mechanism of action is thought to involve inhibition of 5-alpha-reductase, leading to reduced conversion of testosterone to dihydrotestosterone, as well as possible antiandrogenic and anti-inflammatory effects. The identity of "sanmiaoshan" is unclear from available sources; it may refer to a traditional Chinese medicine formula or herb, but no definitive information could be found in the provided data or standard references. As such, the combination's full pharmacological profile cannot be described in detail beyond that contributed by saw palmetto[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saw palmetto + sanmiaoshan.